Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Subunit-selective GABA-A receptor ligands for anxiety, convulsions reported by MS&D

Jan. 26, 1999

L-754030 will enter phase III testing for emesis

Jan. 25, 1999

Preparation and use of neuronal NOS inhibitors disclosed by Astra

Jan. 25, 1999

New 5-HT4 receptor ligands from Synthelabo, their synthesis and use

Jan. 25, 1999

Neurotransmitter reuptake-inhibitory piperidines designed at NeuroSearch

Jan. 25, 1999

Several setbacks reported with Lundbeck antipsychotic

Jan. 22, 1999

Compounds for depression and other CNS disorders reported by Akzo Nobel

Jan. 22, 1999

Ferrer selects new compound for clinical development as atypical antipsychotic

Jan. 21, 1999

Dopaminergic compound evaluated in small group of PD patients; no evidence of efficacy

Jan. 21, 1999

Adolor receives patent protection for novel approach to analgesia

Jan. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...